LONDON (Reuters) – The UK government has sealed two more deals to secure COVID-19 vaccines, buying shots in development from U.S. drugmakers Johnson & Johnson and Novavax Inc, the chair of the UK Vaccine Taskforce Katie Bingham told Sky News on Friday.
In a separate statement, Novavax said the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country.
(Reporting by Alistair Smout; Writing by Josephine Mason; Editing by Jan Harvey)
